UCLA researchers have found patients who do not follow prescribed medication cost the U.S. health care system an estimated $290 billion annually, which contributes to poor clinical outcomes, increased hospitalizations and higher mortality. Researchers conducted focus-group discussions with providers and 100 patients taking 410 medications. Providers felt responsible for assessing and addressing adherence but felt patients were ultimately responsible. Researchers also found interactions were conducted in a way that might address adherence for 62% of the 410 medications. These interactions included simple inquiries about adherence for 31.5% of the medications but in-depth questions for only 4.3%. Patients spontaneously disclosed non-adherence in 51% of 39 identified instances of non-adherence.
Here are four strategies for using digital tools to help consumers buy, manage and use the products you sell.
The United State is not near the top of this list.
The amyloid detection test could help researchers measure the impact of any treatments tried.
Sponsored by Fidelity Investments
Get insights into the mindset that’s driving today’s advisors to make a move--and help realize their unique business vision.
Don’t miss crucial news and insights you need to make informed investment advisory decisions. Join ThinkAdvisor.com now!
- Free unlimited access to ThinkAdvisor.com which provides advisors, like you, with comprehensive coverage of the products, services and trends necessary to guide your clients in making critical wealth, health and life decisions.
- Exclusive discounts on ALM and ThinkAdvisor events.
- Access to other award-winning ALM websites including TreasuryandRisk.com and Law.com.
Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.